메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Design space approach in optimization of fluid bed granulation and tablets compression process

Author keywords

[No Author keywords available]

Indexed keywords

DILUENT; EXCIPIENT; PARACETAMOL;

EID: 84864917117     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/185085     Document Type: Article
Times cited : (16)

References (23)
  • 2
    • 43349088601 scopus 로고    scopus 로고
    • Pharmaceutical quality by design: Product and process development, understanding, and control
    • Yu L. X., Pharmaceutical quality by design: product and process development, understanding, and control Pharmaceutical Research 2008 25 4 781 791
    • (2008) Pharmaceutical Research , vol.25 , Issue.4 , pp. 781-791
    • Yu, L.X.1
  • 4
    • 0034767326 scopus 로고    scopus 로고
    • Process control and scale-up of pharmaceutical wet granulation processes: A review
    • DOI 10.1016/S0939-6411(01)00184-9, PII S0939641101001849
    • Faure A., York P., Rowe R. C., Process control and scale-up of pharmaceutical wet granulation processes: a review European Journal of Pharmaceutics and Biopharmaceutics 2001 52 3 269 277 (Pubitemid 33033180)
    • (2001) European Journal of Pharmaceutics and Biopharmaceutics , vol.52 , Issue.3 , pp. 269-277
    • Faure, A.1    York, P.2    Rowe, R.C.3
  • 6
    • 33947222473 scopus 로고    scopus 로고
    • Experimental study of wet granulation in fluidized bed: Impact of the binder properties on the granule morphology
    • DOI 10.1016/j.ijpharm.2006.10.040, PII S0378517306008982
    • Rajniak P., Mancinelli C., Chern R. T., Stepanek F., Farber L., Hill B. T., Experimental study of wet granulation in fluidized bed: impact of the binder properties on the granule morphology International Journal of Pharmaceutics 2007 334 1-2 92 102 (Pubitemid 46420404)
    • (2007) International Journal of Pharmaceutics , vol.334 , Issue.1-2 , pp. 92-102
    • Rajniak, P.1    Mancinelli, C.2    Chern, R.T.3    Stepanek, F.4    Farber, L.5    Hill, B.T.6
  • 7
    • 27544497972 scopus 로고    scopus 로고
    • Influence of process variable and physicochemical properties on the granulation mechanism of mannitol in a fluid bed top spray granulator
    • DOI 10.1080/03639040500272124
    • Bouffard J., Kaster M., Dumont H., Influence of process variable and physicochemical properties on the granulation mechanism of mannitol in a fluid bed top spray granulator Drug Development and Industrial Pharmacy 2005 31 9 923 933 (Pubitemid 41540945)
    • (2005) Drug Development and Industrial Pharmacy , vol.31 , Issue.9 , pp. 923-933
    • Bouffard, J.1    Kaster, M.2    Dumont, H.3
  • 9
    • 70350683750 scopus 로고    scopus 로고
    • Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design Optimization of fluid bed formulations
    • Tomu I., Alecu C., Rus L. L., Leuuta S. E., Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design Optimization of fluid bed formulations Drug Development and Industrial Pharmacy 2009 35 9 1072 1081
    • (2009) Drug Development and Industrial Pharmacy , vol.35 , Issue.9 , pp. 1072-1081
    • Tomu, I.1    Alecu, C.2    Rus, L.L.3    Leuuta, S.E.4
  • 11
    • 0035124025 scopus 로고    scopus 로고
    • Using experimental design to optimize the process parameters in fluidized bed granulation
    • DOI 10.1081/DDC-100000127
    • Rambali B., Baert L., Thoné D., Massart D. L., Using experimental design to optimize the process parameters in fluidized bed granulation Drug Development and Industrial Pharmacy 2001 27 1 47 55 (Pubitemid 32195360)
    • (2001) Drug Development and Industrial Pharmacy , vol.27 , Issue.1 , pp. 47-55
    • Rambali, B.1    Baert, L.2    Thone, D.3    Massart, D.L.4
  • 13
    • 0035806250 scopus 로고    scopus 로고
    • Using experimental design to optimize the process parameters in fluidized bed granulation on a semi-full scale
    • DOI 10.1016/S0378-5173(01)00658-5, PII S0378517301006585
    • Rambali B., Baert L., Massart D. L., Using experimental design to optimize the process parameters in fluidized bed granulation on a semi-full scale International Journal of Pharmaceutics 2001 220 1-2 149 160 (Pubitemid 32476851)
    • (2001) International Journal of Pharmaceutics , vol.220 , Issue.1-2 , pp. 149-160
    • Rambali, B.1    Baert, L.2    Massart, D.L.3
  • 14
    • 79955037320 scopus 로고    scopus 로고
    • Application of principal component analysis enables to effectively find important physical variables for optimization of fluid bed granulator conditions
    • Otsuka T., Iwao Y., Miyagishima A., Itai S., Application of principal component analysis enables to effectively find important physical variables for optimization of fluid bed granulator conditions International Journal of Pharmaceutics 2011 409 1-2 81 88
    • (2011) International Journal of Pharmaceutics , vol.409 , Issue.12 , pp. 81-88
    • Otsuka, T.1    Iwao, Y.2    Miyagishima, A.3    Itai, S.4
  • 17
    • 0032918303 scopus 로고    scopus 로고
    • The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms
    • DOI 10.1016/S0168-3659(98)00171-0, PII S0168365998001710
    • Chen Y., McCall T. W., Baichwal A. R., Meyer M. C., The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms Journal of Controlled Release 1999 59 1 33 41 (Pubitemid 29187191)
    • (1999) Journal of Controlled Release , vol.59 , Issue.1 , pp. 33-41
    • Chen, Y.1    McCall, T.W.2    Baichwal, A.R.3    Meyer, M.C.4
  • 18
    • 0037151316 scopus 로고    scopus 로고
    • The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit® RS PO as matrix substance
    • DOI 10.1016/S0168-3659(02)00044-5, PII S0168365902000445
    • Ibri S., Jovanovi M., Djuri Z., Paroji J., Solomun L., The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance Journal of Controlled Release 2002 82 2-3 213 222 (Pubitemid 34880179)
    • (2002) Journal of Controlled Release , vol.82 , Issue.2-3 , pp. 213-222
    • Ibri, S.1    Jovanovi, M.2    Djuri, Z.3    Parojci, J.4    Solomun, L.5
  • 19
    • 0141576818 scopus 로고    scopus 로고
    • Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance
    • Ibri S., Jovanovi M., Duri Z., Artificial neural networks in the modeling and optimization of aspirin extended release tablets with Eudragit L 100 as matrix substance AAPS PharmSciTech 2003 4 1 E9
    • (2003) AAPS PharmSciTech , vol.4 , Issue.1 , pp. 9
    • Ibri, S.1    Jovanovi, M.2    Duri, Z.3
  • 21
    • 0033993938 scopus 로고    scopus 로고
    • Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets
    • DOI 10.1081/DDC-100100347
    • Wu T., Pan W., Chen J., Zhang R., Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets Drug Development and Industrial Pharmacy 2000 26 2 211 215 (Pubitemid 30111644)
    • (2000) Drug Development and Industrial Pharmacy , vol.26 , Issue.2 , pp. 211-215
    • Wu, T.1    Pan, W.2    Chen, J.3    Zhang, R.4
  • 22
    • 0042884371 scopus 로고    scopus 로고
    • Neural network based optimization of drug formulations
    • DOI 10.1016/S0169-409X(03)00120-0
    • Takayama K., Fujikawa M., Obata Y., Morishita M., Neural network based optimization of drug formulations Advanced Drug Delivery Reviews 2003 55 9 1217 1231 (Pubitemid 37087925)
    • (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.9 , pp. 1217-1231
    • Takayama, K.1    Fujikawa, M.2    Obata, Y.3    Morishita, M.4
  • 23
    • 80255126570 scopus 로고    scopus 로고
    • 7th Strasbourg, France Council of Europe
    • Council of Europe, European Pharmacopoeia 2011 7th Strasbourg, France Council of Europe
    • (2011) European Pharmacopoeia
    • Of Europe, C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.